Autopsy report · NCT05627479

MAGIK for Femoral/Tibial Shaft Fractures

“Withdrawn due to lack of funding.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

NYU Langone Health

Sponsor type

University, hospital or other

Conditions

Femoral Shaft Fracture; Tibial Shaft Fracture

Interventions

GIK solution; Isotonic Normal Saline Solution

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• The Effects of Sapropterin Dihydrochloride Supplementation on in Vivo Redox Status in Patients With Classical PKU
  “Withdrawn due to no funding” (87% match in meaning)
• Hydroxychloroquine Efficacy in Chronic Urticaria
  “withdrawn, not funded” (86% match in meaning)
• Effects of Lovaza on High Density Lipoprotein (HDL) Composition and Function in Hypertriglyceridemia
  “Withdrawn for administrative reasons.” (84% match in meaning)
• Low-dose Interleukin-2 and Pembrolizumab in Melanoma and Renal Cell Cancer
  “funding was withdrawn” (83% match in meaning)
• The Effect of Light Therapy on Post-Surgical Pain
  “Withdrawn due to lack of resources” (82% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.